Evaluation of Potential Peptide-Based Inhibitors against SARS-CoV-2 and Variants of Concern
Description
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has greatly affected all aspect of life. Although several vaccines and pharmaceuticals have been developed against SARS-CoV-2, the emergence of mutated variants has raised
